News | March 9, 2020
The FDA has reviewed and accepted the New Drug Application (NDA) from Almirall, SA for tirbanibulin, also known as ALM14789, for the treatment of actinic keratosis (AK). The FDA also communicated that it is not currently planning on holding...
Mattel has introduced several new dolls as part of its "Fashionista" line for 2020, including a doll with alopecia and one with vitiligo. Jeanine Downie, MD weighs in. Maui Derm 2020 offers insights on new and emerging therapies for acne, skincancer, and more. Hacking Dermatology has a winner.
Joel Cohen, MD interviews George Martin, MD about the latest developments in actinic keratosis. Dr. Martin said he is eagerly awaiting regulatory review of tirbanibulin, which showed promising results in clinical trials. The two also discuss practical tips and nuances of using 5FU in practice. *Be sure to check out PracticalDermatology.com for a bonus video of Drs. Cohen and Martin talking in even greater depth about treating AK.
Joel Cohen, MD and George Martin, MD go in depth to discuss nuances of treating actinic keratosis in a wide ranging conversation covering the concept of painless PDT and how pretreatment may enhance penetration, an update on ingenol mebutate, and a potential role for combination calcipotriene and 5-FU.
Study: DermTech’s Non-Invasive Gene Expression Testing Improves Early Melanoma Detection
DermWireTV: Barbie Gets Inclusive, Hacking Prizes, Maui Derm Updates
Resident of Distinction Award Celebrates 10th Anniversary at 2020 Caribbean Dermatology Symposium
Cold Plasma Patch May Make Immunotherapy More Effective for Treating Melanoma
FDA Follow-Up Study: Sunscreen Active Ingredients Are Absorbed by Bloodstream